LongCovid
A new perspective article published by Frontiers in Medicine proposes a multipronged clinical trial platform approach that addresses the complexity and heterogeneity of Post-COVID and ME/CFS, enabling to test numerous drugs in clinical trials in a harmonized manner accompanied by comprehensive mechanistic studies.
Frontiers | Fighting Post-COVID and ME/CFS – development of curative therapies (frontiersin.org)
Researchers at the UMCG (University Medical Center Groningen, Netherlands) have recently published a very interesting article in The Lancet about the long-term symptoms related to COVID-19 infection. This publication is based on…
Save the date! Wednesday 10 May 7pm-8pm BST The public are invited to a free webinar to ask questions of a leading specialist about the latest research into…
In the frame of the Initiative Long COVID, launched by German Federal Ministry of Health (Bundesministeriums für Gesundheit, BMG), on the 12th of September 2023, patients, representatives of…
Trying to find a solution to this challenge, researchers from KU Leuven, a research university in Belgium, have been working to develop evidence-based guidelines to help health professionals…